Garly May-Lill, Martins Cesário Lourenco, Balé Carlitos, Baldé Mamadu Aliu, Hedegaard Kathryn Louise, Gustafson Per, Lisse Ida M, Whittle Hilton C, Aaby Peter
Projecto de Saúde de Bandim, Apartado 861, Bissau, Guinea-Bissau.
Vaccine. 2003 Jun 20;21(21-22):2782-90. doi: 10.1016/s0264-410x(03)00181-6.
Previous studies have suggested that the bacille Calmette-Guérin (BCG) vaccine may have a non-specific beneficial effect on childhood survival in areas with high mortality. We examined whether BCG-vaccinated children with a BCG scar or a positive tuberculin reaction had better survival than children without such reactions. As part of an ongoing two-dose measles vaccine trial for which children were recruited at 6 months of age, we examined 1813 children for BCG scar at 6 months of age and 813 BCG-vaccinated children were skin-tested for delayed hypersensitivity to tuberculin, tetanus and diphtheria. We found that BCG-vaccinated children with a BCG scar had significantly lower mortality compared with BCG scar-negative children, the mortality ratio in the first 12 months of follow-up being 0.41 (0.25-0.67). BCG-vaccinated children with a positive tuberculin test had a mortality ratio of 0.45 (0.24-0.85) compared with tuberculin negative children. These results were unchanged by control for potential confounders or using different cut-off points for a tuberculin-positive response. Exclusion of dead children who had HIV antibodies did not modify the estimate (mortality rate (MR)=0.46 (0.23-0.94)). After censoring for tuberculosis (TB) exposure at home, the mortality ratios for having a scar and being tuberculin-positive were 0.46 (0.27-0.79) or 0.42 (0.21-0.84), respectively. Children positive to tetanus or diphtheria in the skin test had the same mortality as children not responding to these vaccine-related antigens. Thus, BCG scar and a positive tuberculin reaction were associated with better survival in early childhood in an area with high mortality. Since nothing similar was found for responders to diphtheria-tetanus-pertussis (DTP) vaccine, and the effect could not be explained by protection against tuberculosis, the effect of BCG vaccination could be due to non-specific immune-stimulation protecting against other infections.
以往研究表明,卡介苗(BCG)疫苗可能对高死亡率地区的儿童生存具有非特异性有益作用。我们研究了有卡介苗疤痕或结核菌素反应呈阳性的接种卡介苗儿童是否比无此类反应的儿童有更好的生存率。作为一项正在进行的两剂次麻疹疫苗试验的一部分,该试验在儿童6月龄时招募儿童,我们在6月龄时检查了1813名儿童的卡介苗疤痕情况,并对813名接种卡介苗的儿童进行了结核菌素、破伤风和白喉迟发型超敏反应的皮肤试验。我们发现,有卡介苗疤痕的接种卡介苗儿童与无卡介苗疤痕儿童相比,死亡率显著更低,随访的前12个月死亡率比值为0.41(0.25 - 0.67)。结核菌素试验呈阳性的接种卡介苗儿童与结核菌素阴性儿童相比,死亡率比值为0.45(0.24 - 0.85)。通过对潜在混杂因素进行控制或使用不同的结核菌素阳性反应临界点,这些结果并未改变。排除有HIV抗体的死亡儿童后,估计值未改变(死亡率(MR)=0.46(0.23 - 0.94))。在对家中结核病(TB)暴露情况进行审查后,有疤痕和结核菌素呈阳性的死亡率比值分别为0.46(0.27 - 0.79)或0.42(0.21 - 0.84)。皮肤试验中对白喉或破伤风呈阳性反应的儿童与对这些疫苗相关抗原无反应的儿童死亡率相同。因此,在高死亡率地区,卡介苗疤痕和结核菌素反应呈阳性与幼儿期更好的生存率相关。由于对白喉 - 破伤风 - 百日咳(DTP)疫苗有反应的儿童未发现类似情况,且该效应无法用预防结核病来解释,卡介苗接种的效应可能是由于非特异性免疫刺激对其他感染的保护作用。